Sales Growth YoY (Last Twelve Months): Metsera Therapeutics (MTSR)

Graphic logo of Metsera Inc (MTSR)

Metsera Inc (MTSR) relies on an asset-light model, outsourcing drug production to external CMOs. Year-over-year sales dynamics based on TTM methodology on GURU.Markets reflect the current value of 0.00, highlighting a dependence on expensive cold-chain logistics. The R&D stage and venture financing drive the company's success, which now depends entirely on FDA regulatory approval.

Sales Growth YoY (Last Twelve Months): Metsera Corp (MTSR) for 11/23/2025 - 11/29/2025

Summary analytical data breakdowns for Metsera, Inc. (MTSR)

- market value and analyst target forecast:
Market Price Metsera Therapeutics|MTSR - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Metsera Inc|MTSR - Enterprise Value
- business book valuation details:
Net Assets per Share Metsera|MTSR - Company Book Value|Market Capitalization to Book Value metsera.com|MTSR - Aggregate Company Assets
- business debt structure and liquidity details:
Total Debt to Equity Ratio Metsera Inc|MTSR - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Metsera|MTSR - Company Aggregate Debts|Debts to Book Value Metsera Corp|MTSR - Company Long-Term Liabilities|Amount of Current Liabilities Metsera|Interim Coverage Ratio metsera.com
- company profitability and valuation multiples indicators:
MTSR - Net Profit|Expected Net Profit Metsera Inc|MTSR - Price to Earnings Ratio|Future Price to Earnings Multiple Metsera Inc|MTSR - PEG Multiple|EV/EBITDA Multiple Metsera Corp|MTSR - Operating profit before deduction of amortization|Earnings per share for the trailing year Metsera|MTSR - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months metsera.com|MTSR - Earnings per share growth in current year|Projected earnings per share growth rate for next year Metsera Inc
- sales and revenue data:
MTSR - Revenue and Sales Volume|Company Future Sales Volume Metsera Therapeutics|MTSR - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Metsera Corp|MTSR - Revenue Growth YoY (Last 12 Months)
Summary company analytics:Metsera Inc
Mass-produced product of Metsera

This indicator measures revenue dynamics over the trailing twelve months relative to the same period last year, reflecting the pace of business scaling. For Metsera Inc (MTSR), this metric confirms the effectiveness of its expansion into the obesity drug segment, which is seeing colossal global demand. By analyzing the year-over-year percentage change in sales volume for the LTM, an investor assesses the speed of market share capture. Steady growth in this figure indicates fundamental stability and high capitalization potential for the company.

Competitor analysis for Metsera Inc

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) MoonLake Corp|Crinetics Corp (CRNX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) newamsterdampharma.com (NAMS)|Revenue Growth YoY (Last 12 Months) soleno.life SLNO|Sales Growth YoY (TTM) FOLD (amicusrx.com)|Annual Revenue Growth (Last Twelve Months) 89bio (ETNB)|Agios - Sales Growth YoY (TTM)|Structure Corp - Revenue Change YoY (Last 12 Months)|mimedx.com (MDXG) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Sales Growth RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) MBX|Sales Growth YoY (Last Twelve Months) Altimmune Pharma (ALT)|Sales Growth YoY (Last Twelve Months) AARD (Aardvark Therapeutics Corp)|Sales Growth YoY (TTM) SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Trailing Twelve Months Revenue Growth|BMEA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Revenue Growth YoY (Last 12 Months)|vTv Therapeutics, Inc. - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Agape ATP Corp.|Revenue Growth YoY (Last 12 Months) Pluri (PLUR)|Sales Growth YoY (TTM) SYBX|Annual Revenue Growth (Last Twelve Months) Lipocine Inc|Sales Growth YoY (Last Twelve Months) Matinas BioPharma Holdings MTNB|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)